Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human serum albumin (HSA) is the most abundant protein in human blood plasma, constituting about half of the total serum protein. It is a highly water-soluble, globular, monomeric protein produced exclusively by the liver. HSA plays critical roles in maintaining oncotic pressure and pH balance in blood, as well as serving as a carrier for hormones, fatty acids, drugs, and other endogenous and exogenous compounds. Abnormal levels can indicate or contribute to disease states, and therapeutically purified HSA is used clinically for volume expansion or replacement therapy. HSA nanoparticles are also explored for targeted drug delivery.
N/A (Transport protein influencing drug pharmacokinetics and distribution)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serum Albumin (Human).